New drug SL-325 tested in healthy people for first time
Knowledge-focused
Ongoing
This early-stage study is testing a new drug called SL-325 in 72 healthy volunteers to see if it is safe and how the body handles it. Participants receive either the drug or a placebo, and researchers monitor for side effects and measure drug levels in the blood. This study does …
Phase: PHASE1 • Sponsor: Shattuck Labs, Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 05:33 UTC